English

HK IPO Fund

A Hong Kong IPO strategy product from MaSlow for investors who meet the eligibility requirements.

Through professional fund-based operations, the product centrally handles research, capital scheduling, subscription, allotment and exit management. Users can participate in HK IPO investment simply by holding fund shares, without subscribing deal by deal.

Highlights

Short Cycle

The product covers the full HK IPO lifecycle. Compared with long-term closed-end products, the capital cycle and exit pace are clear and controllable; lock-up periods, redemption windows and settlement times are subject to the final product terms.

Flexible Participation

Participate based on your own capital arrangements, subject to eligibility, open periods and minimum investment requirements — no separate account or subscription funds needed for each IPO.

Unified Execution

Screening, verification, subscription, allotment records, post-listing management and settlement are handled uniformly by professional teams and execution institutions per the product documents.

Shared Allotment Results

By holding fund shares, users share the overall allotment and investment results at the portfolio level according to product rules, no longer relying on individual-account IPO lotteries.

Who It Serves

  • Investors who want HK IPO opportunities but have no time to research and operate deal by deal;
  • Investors who want to reduce the impact of zero allotment in personal accounts;
  • Eligible investors with clear requirements on capital cycles and exit flexibility;
  • Family offices and other professional investors who meet the product eligibility criteria.

Core Value

  • Lower the operational threshold of research, subscription and management;
  • New listing projects handled uniformly by a professional team;
  • Participate in portfolio-level allotment results through fund shares;
  • Capital cycles and investment records managed in a productized way;
  • Clearer information on subscription, allotment, exit and settlement.
Risk Boundary
1

HK IPO allotment, listing performance and exit results are uncertain, and the product carries corresponding risks;

2

Risk of zero or low allotment;

3

Risk of price decline after listing;

4

Market liquidity and price volatility risks;

5

Concentration risk;

6

Lock-up, redemption and settlement timing risks;

7

Manager, operator, execution institution and counterparty risks;

8

FX, fee, tax and jurisdiction risks.